Kazia Therapeutics Ltd Sponsored ADR
(NASDAQ : NVGN)

( )
NVGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.89%179.941.2%$613.29m
CELGCelgene Corporation
1.37%77.661.2%$573.03m
GILDGilead Sciences, Inc.
0.50%68.170.9%$553.71m
BIIBBiogen Inc.
1.45%283.751.2%$528.19m
REGNRegeneron Pharmaceuticals, Inc.
0.21%295.312.6%$309.20m
ILMNIllumina, Inc.
0.34%271.733.5%$236.17m
VRTXVertex Pharmaceuticals Incorporated
0.45%156.981.9%$231.45m
ALXNAlexion Pharmaceuticals, Inc.
-0.74%118.132.0%$223.26m
AAgilent Technologies, Inc.
-0.48%64.531.5%$209.75m
NKTRNektar Therapeutics
1.04%82.806.0%$200.36m
INCYIncyte Corporation
0.02%66.572.5%$176.67m
SRPTSarepta Therapeutics, Inc.
-0.29%88.9616.6%$124.64m
BMRNBioMarin Pharmaceutical Inc.
0.97%88.464.4%$118.47m
EXASExact Sciences Corporation
-3.10%51.3525.5%$112.48m
BLUEBluebird Bio, Inc.
2.02%189.4015.7%$96.63m

Company Profile

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Hornsby, Australia.